Dr. Ignacio Faus
Dr.Ignacio Faus is currently Chief Executive Officer of Genmedica Therapeutics, a clinical-stage biopharmaceutical company that develops new medications for the diabetic patient.
Prior to that he founded, grew and sold Palau Pharma, a biotechnology company that was spun out from the R&D Unit of Grupo Uriach, one of the leading family-owned European pharmaceutical companies, with sales over €150 M and over 600 employees.
During his professional life Dr. Faus has led both R&D and Business Development teams in mid size companies (Ferrer, Uriach) and in large multinational companies (Bristol-Myers Squibb). He has negotiated and executed a large number of transactions in pharmaceuticals, medical devices, diagnostics and consumer healthcare products.
Dr. Faus received a Ph.D in biochemistry from Indiana University and an MBA from the Kellogg School of Management (Northwestern University). He is fluent in Spanish, English, French and conversational in German.